カテゴリー： 世界, 医療/バイオ, QYResearch

静脈血栓塞栓症治療オプションの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Venous Thromboembolism Treatment Options Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX09303）・商品コード：QY22JLX09303
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：94
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、静脈血栓塞栓症治療オプションのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に静脈血栓塞栓症治療オプションの世界市場のxxx％を占める「上部空気圧迫スリーブ」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
静脈血栓塞栓症治療オプションの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの静脈血栓塞栓症治療オプション市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

静脈血栓塞栓症治療オプションのグローバル主要企業には、AngioDynamics、Cardinal Health Inc.、BTG International Ltd.、Stryker Corporation、DJO Global Inc.、EKOS Corp、Teleflex Inc., Boston Scientific Corp.、Janssen Pharmaceuticals, Incなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

静脈血栓塞栓症治療オプション市場は、種類と用途によって区分されます。世界の静脈血栓塞栓症治療オプション市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
上部空気圧迫スリーブ、下部空気圧圧縮スリーブ、永久下大静脈フィルター、その他

【用途別セグメント】
病院、カテーテル検査室、外来手術センター

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 静脈血栓塞栓症治療オプション製品概要
- 種類別市場（上部空気圧迫スリーブ、下部空気圧圧縮スリーブ、永久下大静脈フィルター、その他）
- 用途別市場（病院、カテーテル検査室、外来手術センター）
- 調査の目的
・エグゼクティブサマリー
- 世界の静脈血栓塞栓症治療オプション販売量予測2017-2028
- 世界の静脈血栓塞栓症治療オプション売上予測2017-2028
- 静脈血栓塞栓症治療オプションの地域別販売量
- 静脈血栓塞栓症治療オプションの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別静脈血栓塞栓症治療オプション販売量
- 主要メーカー別静脈血栓塞栓症治療オプション売上
- 主要メーカー別静脈血栓塞栓症治療オプション価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（上部空気圧迫スリーブ、下部空気圧圧縮スリーブ、永久下大静脈フィルター、その他）
- 静脈血栓塞栓症治療オプションの種類別販売量
- 静脈血栓塞栓症治療オプションの種類別売上
- 静脈血栓塞栓症治療オプションの種類別価格
・用途別市場規模（病院、カテーテル検査室、外来手術センター）
- 静脈血栓塞栓症治療オプションの用途別販売量
- 静脈血栓塞栓症治療オプションの用途別売上
- 静脈血栓塞栓症治療オプションの用途別価格
・北米市場
- 北米の静脈血栓塞栓症治療オプション市場規模（種類別、用途別）
- 主要国別の静脈血栓塞栓症治療オプション市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの静脈血栓塞栓症治療オプション市場規模（種類別、用途別）
- 主要国別の静脈血栓塞栓症治療オプション市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の静脈血栓塞栓症治療オプション市場規模（種類別、用途別）
- 主要国別の静脈血栓塞栓症治療オプション市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の静脈血栓塞栓症治療オプション市場規模（種類別、用途別）
- 主要国別の静脈血栓塞栓症治療オプション市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの静脈血栓塞栓症治療オプション市場規模（種類別、用途別）
- 主要国別の静脈血栓塞栓症治療オプション市場規模（トルコ、サウジアラビア）
・企業情報
AngioDynamics、Cardinal Health Inc.、BTG International Ltd.、Stryker Corporation、DJO Global Inc.、EKOS Corp、Teleflex Inc., Boston Scientific Corp.、Janssen Pharmaceuticals, Inc
・産業チェーン及び販売チャネル分析
- 静脈血栓塞栓症治療オプションの産業チェーン分析
- 静脈血栓塞栓症治療オプションの原材料
- 静脈血栓塞栓症治療オプションの生産プロセス
- 静脈血栓塞栓症治療オプションの販売及びマーケティング
- 静脈血栓塞栓症治療オプションの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 静脈血栓塞栓症治療オプションの産業動向
- 静脈血栓塞栓症治療オプションのマーケットドライバー
- 静脈血栓塞栓症治療オプションの課題
- 静脈血栓塞栓症治療オプションの阻害要因
・主な調査結果

The most common treatment for deep vein thrombosis is the use of anticoagulants, also known as blood thinners. These medicines, which can be taken by injection or pill, can reduce your blood’s ability to clot. They don’t break down existing clots, but they prevent them from getting bigger and reduce the risk of more clots forming. Injectable drugs can be given either subcutaneously or intravenously.
Market Analysis and Insights: Global Venous Thromboembolism Treatment Options Market
Due to the COVID-19 pandemic, the global Venous Thromboembolism Treatment Options market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Upper Pneumatic Compression Sleeves accounting for % of the Venous Thromboembolism Treatment Options global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Venous Thromboembolism Treatment Options market size is valued at US$ million in 2021, while the US and Europe Venous Thromboembolism Treatment Options are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Venous Thromboembolism Treatment Options landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Venous Thromboembolism Treatment Options include AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, Teleflex Inc., Boston Scientific Corp. and Janssen Pharmaceuticals, Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Venous Thromboembolism Treatment Options Scope and Segment
Venous Thromboembolism Treatment Options market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Venous Thromboembolism Treatment Options market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Upper Pneumatic Compression Sleeves
Lower Pneumatic Compression Sleeves
Permanent Inferior Vena Cava Filters
Others
Segment by Application
Hospitals
Catheterisation Laboratories
Ambulatory Surgical Centers
By Company
AngioDynamics
Cardinal Health Inc.
BTG International Ltd.
Stryker Corporation
DJO Global Inc.
EKOS Corp
Teleflex Inc., Boston Scientific Corp.
Janssen Pharmaceuticals, Inc
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Venous Thromboembolism Treatment Options Product Introduction
1.2 Market by Type
1.2.1 Global Venous Thromboembolism Treatment Options Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Upper Pneumatic Compression Sleeves
1.2.3 Lower Pneumatic Compression Sleeves
1.2.4 Permanent Inferior Vena Cava Filters
1.2.5 Others
1.3 Market by Application
1.3.1 Global Venous Thromboembolism Treatment Options Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Catheterisation Laboratories
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Venous Thromboembolism Treatment Options Sales Estimates and Forecasts 2017-2028
2.2 Global Venous Thromboembolism Treatment Options Revenue Estimates and Forecasts 2017-2028
2.3 Global Venous Thromboembolism Treatment Options Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Venous Thromboembolism Treatment Options Sales by Region
2.4.1 Global Venous Thromboembolism Treatment Options Sales by Region (2017-2022)
2.4.2 Global Sales Venous Thromboembolism Treatment Options by Region (2023-2028)
2.5 Global Venous Thromboembolism Treatment Options Revenue by Region
2.5.1 Global Venous Thromboembolism Treatment Options Revenue by Region (2017-2022)
2.5.2 Global Venous Thromboembolism Treatment Options Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Venous Thromboembolism Treatment Options Sales by Manufacturers
3.1.1 Global Top Venous Thromboembolism Treatment Options Manufacturers by Sales (2017-2022)
3.1.2 Global Venous Thromboembolism Treatment Options Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Venous Thromboembolism Treatment Options in 2021
3.2 Global Venous Thromboembolism Treatment Options Revenue by Manufacturers
3.2.1 Global Venous Thromboembolism Treatment Options Revenue by Manufacturers (2017-2022)
3.2.2 Global Venous Thromboembolism Treatment Options Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Venous Thromboembolism Treatment Options Revenue in 2021
3.3 Global Venous Thromboembolism Treatment Options Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Venous Thromboembolism Treatment Options Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Venous Thromboembolism Treatment Options Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Venous Thromboembolism Treatment Options Sales by Type
4.1.1 Global Venous Thromboembolism Treatment Options Historical Sales by Type (2017-2022)
4.1.2 Global Venous Thromboembolism Treatment Options Forecasted Sales by Type (2023-2028)
4.1.3 Global Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2028)
4.2 Global Venous Thromboembolism Treatment Options Revenue by Type
4.2.1 Global Venous Thromboembolism Treatment Options Historical Revenue by Type (2017-2022)
4.2.2 Global Venous Thromboembolism Treatment Options Forecasted Revenue by Type (2023-2028)
4.2.3 Global Venous Thromboembolism Treatment Options Revenue Market Share by Type (2017-2028)
4.3 Global Venous Thromboembolism Treatment Options Price by Type
4.3.1 Global Venous Thromboembolism Treatment Options Price by Type (2017-2022)
4.3.2 Global Venous Thromboembolism Treatment Options Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Venous Thromboembolism Treatment Options Sales by Application
5.1.1 Global Venous Thromboembolism Treatment Options Historical Sales by Application (2017-2022)
5.1.2 Global Venous Thromboembolism Treatment Options Forecasted Sales by Application (2023-2028)
5.1.3 Global Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
5.2 Global Venous Thromboembolism Treatment Options Revenue by Application
5.2.1 Global Venous Thromboembolism Treatment Options Historical Revenue by Application (2017-2022)
5.2.2 Global Venous Thromboembolism Treatment Options Forecasted Revenue by Application (2023-2028)
5.2.3 Global Venous Thromboembolism Treatment Options Revenue Market Share by Application (2017-2028)
5.3 Global Venous Thromboembolism Treatment Options Price by Application
5.3.1 Global Venous Thromboembolism Treatment Options Price by Application (2017-2022)
5.3.2 Global Venous Thromboembolism Treatment Options Price Forecast by Application (2023-2028)
6 North America
6.1 North America Venous Thromboembolism Treatment Options Market Size by Type
6.1.1 North America Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
6.1.2 North America Venous Thromboembolism Treatment Options Revenue by Type (2017-2028)
6.2 North America Venous Thromboembolism Treatment Options Market Size by Application
6.2.1 North America Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
6.2.2 North America Venous Thromboembolism Treatment Options Revenue by Application (2017-2028)
6.3 North America Venous Thromboembolism Treatment Options Market Size by Country
6.3.1 North America Venous Thromboembolism Treatment Options Sales by Country (2017-2028)
6.3.2 North America Venous Thromboembolism Treatment Options Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Venous Thromboembolism Treatment Options Market Size by Type
7.1.1 Europe Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
7.1.2 Europe Venous Thromboembolism Treatment Options Revenue by Type (2017-2028)
7.2 Europe Venous Thromboembolism Treatment Options Market Size by Application
7.2.1 Europe Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
7.2.2 Europe Venous Thromboembolism Treatment Options Revenue by Application (2017-2028)
7.3 Europe Venous Thromboembolism Treatment Options Market Size by Country
7.3.1 Europe Venous Thromboembolism Treatment Options Sales by Country (2017-2028)
7.3.2 Europe Venous Thromboembolism Treatment Options Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Venous Thromboembolism Treatment Options Market Size by Type
8.1.1 Asia Pacific Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
8.1.2 Asia Pacific Venous Thromboembolism Treatment Options Revenue by Type (2017-2028)
8.2 Asia Pacific Venous Thromboembolism Treatment Options Market Size by Application
8.2.1 Asia Pacific Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
8.2.2 Asia Pacific Venous Thromboembolism Treatment Options Revenue by Application (2017-2028)
8.3 Asia Pacific Venous Thromboembolism Treatment Options Market Size by Region
8.3.1 Asia Pacific Venous Thromboembolism Treatment Options Sales by Region (2017-2028)
8.3.2 Asia Pacific Venous Thromboembolism Treatment Options Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Venous Thromboembolism Treatment Options Market Size by Type
9.1.1 Latin America Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
9.1.2 Latin America Venous Thromboembolism Treatment Options Revenue by Type (2017-2028)
9.2 Latin America Venous Thromboembolism Treatment Options Market Size by Application
9.2.1 Latin America Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
9.2.2 Latin America Venous Thromboembolism Treatment Options Revenue by Application (2017-2028)
9.3 Latin America Venous Thromboembolism Treatment Options Market Size by Country
9.3.1 Latin America Venous Thromboembolism Treatment Options Sales by Country (2017-2028)
9.3.2 Latin America Venous Thromboembolism Treatment Options Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Venous Thromboembolism Treatment Options Market Size by Type
10.1.1 Middle East and Africa Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
10.1.2 Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Type (2017-2028)
10.2 Middle East and Africa Venous Thromboembolism Treatment Options Market Size by Application
10.2.1 Middle East and Africa Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
10.2.2 Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Application (2017-2028)
10.3 Middle East and Africa Venous Thromboembolism Treatment Options Market Size by Country
10.3.1 Middle East and Africa Venous Thromboembolism Treatment Options Sales by Country (2017-2028)
10.3.2 Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AngioDynamics
11.1.1 AngioDynamics Corporation Information
11.1.2 AngioDynamics Overview
11.1.3 AngioDynamics Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AngioDynamics Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AngioDynamics Recent Developments
11.2 Cardinal Health Inc.
11.2.1 Cardinal Health Inc. Corporation Information
11.2.2 Cardinal Health Inc. Overview
11.2.3 Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cardinal Health Inc. Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cardinal Health Inc. Recent Developments
11.3 BTG International Ltd.
11.3.1 BTG International Ltd. Corporation Information
11.3.2 BTG International Ltd. Overview
11.3.3 BTG International Ltd. Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BTG International Ltd. Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BTG International Ltd. Recent Developments
11.4 Stryker Corporation
11.4.1 Stryker Corporation Corporation Information
11.4.2 Stryker Corporation Overview
11.4.3 Stryker Corporation Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Stryker Corporation Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Stryker Corporation Recent Developments
11.5 DJO Global Inc.
11.5.1 DJO Global Inc. Corporation Information
11.5.2 DJO Global Inc. Overview
11.5.3 DJO Global Inc. Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 DJO Global Inc. Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 DJO Global Inc. Recent Developments
11.6 EKOS Corp
11.6.1 EKOS Corp Corporation Information
11.6.2 EKOS Corp Overview
11.6.3 EKOS Corp Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 EKOS Corp Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 EKOS Corp Recent Developments
11.7 Teleflex Inc., Boston Scientific Corp.
11.7.1 Teleflex Inc., Boston Scientific Corp. Corporation Information
11.7.2 Teleflex Inc., Boston Scientific Corp. Overview
11.7.3 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Teleflex Inc., Boston Scientific Corp. Recent Developments
11.8 Janssen Pharmaceuticals, Inc
11.8.1 Janssen Pharmaceuticals, Inc Corporation Information
11.8.2 Janssen Pharmaceuticals, Inc Overview
11.8.3 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Janssen Pharmaceuticals, Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Venous Thromboembolism Treatment Options Industry Chain Analysis
12.2 Venous Thromboembolism Treatment Options Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Venous Thromboembolism Treatment Options Production Mode & Process
12.4 Venous Thromboembolism Treatment Options Sales and Marketing
12.4.1 Venous Thromboembolism Treatment Options Sales Channels
12.4.2 Venous Thromboembolism Treatment Options Distributors
12.5 Venous Thromboembolism Treatment Options Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Venous Thromboembolism Treatment Options Industry Trends
13.2 Venous Thromboembolism Treatment Options Market Drivers
13.3 Venous Thromboembolism Treatment Options Market Challenges
13.4 Venous Thromboembolism Treatment Options Market Restraints
14 Key Findings in The Global Venous Thromboembolism Treatment Options Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Venous Thromboembolism Treatment Options Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Upper Pneumatic Compression Sleeves
Table 3. Major Manufacturers of Lower Pneumatic Compression Sleeves
Table 4. Major Manufacturers of Permanent Inferior Vena Cava Filters
Table 5. Major Manufacturers of Others
Table 6. Global Venous Thromboembolism Treatment Options Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Venous Thromboembolism Treatment Options Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Venous Thromboembolism Treatment Options Sales by Region (2017-2022) & (K Units)
Table 9. Global Venous Thromboembolism Treatment Options Sales Market Share by Region (2017-2022)
Table 10. Global Venous Thromboembolism Treatment Options Sales by Region (2023-2028) & (K Units)
Table 11. Global Venous Thromboembolism Treatment Options Sales Market Share by Region (2023-2028)
Table 12. Global Venous Thromboembolism Treatment Options Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Venous Thromboembolism Treatment Options Revenue Market Share by Region (2017-2022)
Table 14. Global Venous Thromboembolism Treatment Options Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Venous Thromboembolism Treatment Options Revenue Market Share by Region (2023-2028)
Table 16. Global Venous Thromboembolism Treatment Options Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Venous Thromboembolism Treatment Options Sales Share by Manufacturers (2017-2022)
Table 18. Global Venous Thromboembolism Treatment Options Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Venous Thromboembolism Treatment Options Revenue Share by Manufacturers (2017-2022)
Table 20. Venous Thromboembolism Treatment Options Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Venous Thromboembolism Treatment Options Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Venous Thromboembolism Treatment Options by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Treatment Options as of 2021)
Table 23. Venous Thromboembolism Treatment Options Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Venous Thromboembolism Treatment Options Product Offered
Table 25. Date of Manufacturers Enter into Venous Thromboembolism Treatment Options Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Venous Thromboembolism Treatment Options Sales by Type (2017-2022) & (K Units)
Table 28. Global Venous Thromboembolism Treatment Options Sales by Type (2023-2028) & (K Units)
Table 29. Global Venous Thromboembolism Treatment Options Sales Share by Type (2017-2022)
Table 30. Global Venous Thromboembolism Treatment Options Sales Share by Type (2023-2028)
Table 31. Global Venous Thromboembolism Treatment Options Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Venous Thromboembolism Treatment Options Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Venous Thromboembolism Treatment Options Revenue Share by Type (2017-2022)
Table 34. Global Venous Thromboembolism Treatment Options Revenue Share by Type (2023-2028)
Table 35. Venous Thromboembolism Treatment Options Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Venous Thromboembolism Treatment Options Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Venous Thromboembolism Treatment Options Sales by Application (2017-2022) & (K Units)
Table 38. Global Venous Thromboembolism Treatment Options Sales by Application (2023-2028) & (K Units)
Table 39. Global Venous Thromboembolism Treatment Options Sales Share by Application (2017-2022)
Table 40. Global Venous Thromboembolism Treatment Options Sales Share by Application (2023-2028)
Table 41. Global Venous Thromboembolism Treatment Options Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Venous Thromboembolism Treatment Options Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Venous Thromboembolism Treatment Options Revenue Share by Application (2017-2022)
Table 44. Global Venous Thromboembolism Treatment Options Revenue Share by Application (2023-2028)
Table 45. Venous Thromboembolism Treatment Options Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Venous Thromboembolism Treatment Options Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Venous Thromboembolism Treatment Options Sales by Type (2017-2022) & (K Units)
Table 48. North America Venous Thromboembolism Treatment Options Sales by Type (2023-2028) & (K Units)
Table 49. North America Venous Thromboembolism Treatment Options Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Venous Thromboembolism Treatment Options Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Venous Thromboembolism Treatment Options Sales by Application (2017-2022) & (K Units)
Table 52. North America Venous Thromboembolism Treatment Options Sales by Application (2023-2028) & (K Units)
Table 53. North America Venous Thromboembolism Treatment Options Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Venous Thromboembolism Treatment Options Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Venous Thromboembolism Treatment Options Sales by Country (2017-2022) & (K Units)
Table 56. North America Venous Thromboembolism Treatment Options Sales by Country (2023-2028) & (K Units)
Table 57. North America Venous Thromboembolism Treatment Options Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Venous Thromboembolism Treatment Options Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Venous Thromboembolism Treatment Options Sales by Type (2017-2022) & (K Units)
Table 60. Europe Venous Thromboembolism Treatment Options Sales by Type (2023-2028) & (K Units)
Table 61. Europe Venous Thromboembolism Treatment Options Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Venous Thromboembolism Treatment Options Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Venous Thromboembolism Treatment Options Sales by Application (2017-2022) & (K Units)
Table 64. Europe Venous Thromboembolism Treatment Options Sales by Application (2023-2028) & (K Units)
Table 65. Europe Venous Thromboembolism Treatment Options Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Venous Thromboembolism Treatment Options Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Venous Thromboembolism Treatment Options Sales by Country (2017-2022) & (K Units)
Table 68. Europe Venous Thromboembolism Treatment Options Sales by Country (2023-2028) & (K Units)
Table 69. Europe Venous Thromboembolism Treatment Options Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Venous Thromboembolism Treatment Options Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Venous Thromboembolism Treatment Options Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Venous Thromboembolism Treatment Options Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Venous Thromboembolism Treatment Options Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Venous Thromboembolism Treatment Options Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Venous Thromboembolism Treatment Options Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Venous Thromboembolism Treatment Options Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Venous Thromboembolism Treatment Options Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Venous Thromboembolism Treatment Options Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Venous Thromboembolism Treatment Options Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Venous Thromboembolism Treatment Options Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Venous Thromboembolism Treatment Options Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Venous Thromboembolism Treatment Options Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Venous Thromboembolism Treatment Options Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Venous Thromboembolism Treatment Options Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Venous Thromboembolism Treatment Options Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Venous Thromboembolism Treatment Options Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Venous Thromboembolism Treatment Options Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Venous Thromboembolism Treatment Options Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Venous Thromboembolism Treatment Options Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Venous Thromboembolism Treatment Options Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Venous Thromboembolism Treatment Options Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Venous Thromboembolism Treatment Options Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Venous Thromboembolism Treatment Options Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Venous Thromboembolism Treatment Options Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Country (2023-2028) & (US$ Million)
Table 107. AngioDynamics Corporation Information
Table 108. AngioDynamics Description and Major Businesses
Table 109. AngioDynamics Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. AngioDynamics Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. AngioDynamics Recent Developments
Table 112. Cardinal Health Inc. Corporation Information
Table 113. Cardinal Health Inc. Description and Major Businesses
Table 114. Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Cardinal Health Inc. Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Cardinal Health Inc. Recent Developments
Table 117. BTG International Ltd. Corporation Information
Table 118. BTG International Ltd. Description and Major Businesses
Table 119. BTG International Ltd. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. BTG International Ltd. Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. BTG International Ltd. Recent Developments
Table 122. Stryker Corporation Corporation Information
Table 123. Stryker Corporation Description and Major Businesses
Table 124. Stryker Corporation Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Stryker Corporation Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Stryker Corporation Recent Developments
Table 127. DJO Global Inc. Corporation Information
Table 128. DJO Global Inc. Description and Major Businesses
Table 129. DJO Global Inc. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. DJO Global Inc. Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. DJO Global Inc. Recent Developments
Table 132. EKOS Corp Corporation Information
Table 133. EKOS Corp Description and Major Businesses
Table 134. EKOS Corp Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. EKOS Corp Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. EKOS Corp Recent Developments
Table 137. Teleflex Inc., Boston Scientific Corp. Corporation Information
Table 138. Teleflex Inc., Boston Scientific Corp. Description and Major Businesses
Table 139. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Teleflex Inc., Boston Scientific Corp. Recent Developments
Table 142. Janssen Pharmaceuticals, Inc Corporation Information
Table 143. Janssen Pharmaceuticals, Inc Description and Major Businesses
Table 144. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Janssen Pharmaceuticals, Inc Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Venous Thromboembolism Treatment Options Distributors List
Table 150. Venous Thromboembolism Treatment Options Customers List
Table 151. Venous Thromboembolism Treatment Options Market Trends
Table 152. Venous Thromboembolism Treatment Options Market Drivers
Table 153. Venous Thromboembolism Treatment Options Market Challenges
Table 154. Venous Thromboembolism Treatment Options Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Venous Thromboembolism Treatment Options Product Picture
Figure 3. Global Venous Thromboembolism Treatment Options Market Share by Type in 2021 & 2028
Figure 3. Upper Pneumatic Compression Sleeves Product Picture
Figure 4. Lower Pneumatic Compression Sleeves Product Picture
Figure 5. Permanent Inferior Vena Cava Filters Product Picture
Figure 6. Others Product Picture
Figure 7. Global Venous Thromboembolism Treatment Options Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Catheterisation Laboratories
Figure 10. Ambulatory Surgical Centers
Figure 11. Venous Thromboembolism Treatment Options Report Years Considered
Figure 12. Global Venous Thromboembolism Treatment Options Sales 2017-2028 (K Units)
Figure 13. Global Venous Thromboembolism Treatment Options Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Venous Thromboembolism Treatment Options Revenue 2017-2028 (US$ Million)
Figure 15. Global Venous Thromboembolism Treatment Options Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Venous Thromboembolism Treatment Options Sales Market Share by Region (2017-2022)
Figure 17. Global Venous Thromboembolism Treatment Options Sales Market Share by Region (2023-2028)
Figure 18. North America Venous Thromboembolism Treatment Options Sales YoY (2017-2028) & (K Units)
Figure 19. North America Venous Thromboembolism Treatment Options Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Venous Thromboembolism Treatment Options Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Venous Thromboembolism Treatment Options Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Venous Thromboembolism Treatment Options Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Venous Thromboembolism Treatment Options Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Venous Thromboembolism Treatment Options Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Venous Thromboembolism Treatment Options Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Venous Thromboembolism Treatment Options Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Venous Thromboembolism Treatment Options Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Venous Thromboembolism Treatment Options Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Venous Thromboembolism Treatment Options in the World: Market Share by Venous Thromboembolism Treatment Options Revenue in 2021
Figure 30. Global Venous Thromboembolism Treatment Options Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2028)
Figure 32. Global Venous Thromboembolism Treatment Options Revenue Market Share by Type (2017-2028)
Figure 33. Global Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
Figure 34. Global Venous Thromboembolism Treatment Options Revenue Market Share by Application (2017-2028)
Figure 35. North America Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2028)
Figure 36. North America Venous Thromboembolism Treatment Options Revenue Market Share by Type (2017-2028)
Figure 37. North America Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
Figure 38. North America Venous Thromboembolism Treatment Options Revenue Market Share by Application (2017-2028)
Figure 39. North America Venous Thromboembolism Treatment Options Sales Share by Country (2017-2028)
Figure 40. North America Venous Thromboembolism Treatment Options Revenue Share by Country (2017-2028)
Figure 41. United States Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2028)
Figure 44. Europe Venous Thromboembolism Treatment Options Revenue Market Share by Type (2017-2028)
Figure 45. Europe Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
Figure 46. Europe Venous Thromboembolism Treatment Options Revenue Market Share by Application (2017-2028)
Figure 47. Europe Venous Thromboembolism Treatment Options Sales Share by Country (2017-2028)
Figure 48. Europe Venous Thromboembolism Treatment Options Revenue Share by Country (2017-2028)
Figure 49. Germany Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 50. France Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Venous Thromboembolism Treatment Options Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Venous Thromboembolism Treatment Options Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Venous Thromboembolism Treatment Options Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Venous Thromboembolism Treatment Options Revenue Share by Region (2017-2028)
Figure 60. China Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 63. India Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2028)
Figure 70. Latin America Venous Thromboembolism Treatment Options Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
Figure 72. Latin America Venous Thromboembolism Treatment Options Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Venous Thromboembolism Treatment Options Sales Share by Country (2017-2028)
Figure 74. Latin America Venous Thromboembolism Treatment Options Revenue Share by Country (2017-2028)
Figure 75. Mexico Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Venous Thromboembolism Treatment Options Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Venous Thromboembolism Treatment Options Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Venous Thromboembolism Treatment Options Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Venous Thromboembolism Treatment Options Revenue Share by Country (2017-2028)
Figure 84. Turkey Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Venous Thromboembolism Treatment Options Revenue (2017-2028) & (US$ Million)
Figure 87. Venous Thromboembolism Treatment Options Value Chain
Figure 88. Venous Thromboembolism Treatment Options Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed


★調査レポート[静脈血栓塞栓症治療オプションの世界市場インサイト・予測（～2028年）] (コード：QY22JLX09303)販売に関する免責事項を必ずご確認ください。
★調査レポート[静脈血栓塞栓症治療オプションの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 静脈逆流症治療のグローバル市場2023年：手術治療、非外科的治療
  • 世界の静脈性潰瘍用治療市場予測 2023年-2029年
  • 静脈インターベンション装置のグローバル市場2023年：大静脈フィルター、血栓吸引システム、高周波アブレーションシステム、腸骨静脈ステント
  • 医療用静脈血採取針の世界市場インサイト・予測（～2028年）
  • 静脈内留針の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆